Commencement of the 2017 Vision Seminar series at UMass Chan Medical School with a lecture by Dr. Hemant Khanna
Date Posted: Monday, January 23, 2017On Thursday January 19, 2017 Dr. Hemant Khanna highlighted critical roadblocks in designing gene augmentation therapy for X-linked retinal degeneration due to RPGR mutations. He also provided insights into developing novel therapeutic molecules for treating childhood blindness disorder Leber congenital amaurosis due to CEP290 mutations. Dr. Khanna’s lecture is a part of the UMass Ophthalmology & Visual Sciences Vision Seminar Series.
